First Hawaiian Bank Tekla Life Sciences Investors Transaction History

First Hawaiian Bank

$3.01 Billion
Q4 2024

Shares

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Jul 15, 2019	SELL	$15.54 - $17.47 $8,158 - $9,171	-525 Closed	0 $0
Q3 2018 Oct 16, 2018	BUY	$18.89 - $20.49 $9,917 - $10,757	525 New	525 $11,000

Others Institutions Holding HQL

# of Institutions

78

Shares Held

9.65M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$48.6 Million
1.11% of portfolio
Penserra Capital Management LLC Orinda, CA

828K
Shares

$11.7 Million
0.2% of portfolio
Karpus Management, Inc. Pittsford, NY

490K
Shares

$6.94 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.91 Million
0.12% of portfolio
Absolute Investment Advisers LLC

400K
Shares

$5.66 Million
0.67% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.